Amphastar Pharmaceuticals Inc (NAS:AMPH)
$ 42.44 1.14 (2.76%) Market Cap: 2.08 Bil Enterprise Value: 2.36 Bil PE Ratio: 14.69 PB Ratio: 3.08 GF Score: 77/100

Q3 2019 Amphastar Pharmaceuticals Inc Earnings Call Transcript

Nov 07, 2019 / 10:00PM GMT
Release Date Price: $19.12 (+0.21%)
Operator

This conference call may contain forward-looking statements, including statements relating to Amphastar Pharmaceuticals. These statements are not historical facts but rather based on Amphastar Pharmaceutical's current expectations, estimates and projections regarding Amphastar Pharmaceuticals' business, operations and other similar or related factors. Words such as may, will, could, would, should, anticipate, predict, potential, continue, expects, intends, plans, projects, believes, estimates and other similar or related expressions are used to identify these forward-looking statements.

These statements are only predictions and [or] such are not guarantees of future performance. And they involve risks, uncertainties and assumptions that are difficult or impossible to predict. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including these described from time to time in Amphastar Pharmaceuticals' filings with the SEC.

At this time, I'd like to turn the call over to Mr. Jason Shandell, President of Amphastar. Please go

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot